Cov kws tshuaj ntsuam Slash Y-mAbs Therapeutics Nqe Lub Hom Phiaj Raws li qhov tsis paub tseeb Looms dhau Neuroblastoma Cia siab

  • Hnub Friday, FDA's Oncologic Drugs Advisory Committee (ODAC) tau pov npav 16 rau 0 tias Y-mAbs Therapeutics Inc (Nasdaq: YMAB) tsis tau muab pov thawj txaus los xaus qhov ntawd omburtamab txhim kho kev ciaj sia tag nrho.

  • Guggenheim hais tias xov xwm yog kev poob siab, slashing lub tus nqi phiaj los ntawm $ 26 txog $ 18, muab qhov tsis zoo ntawm daim ntawv pov thawj tseem ceeb uas muaj nqis txog $ 70 lab hauv cov nyiaj tau los thiab cov nyiaj ntsuab tam sim no mus rau nruab nrab xyoo 2024. Analyst tuav lub Yuav ntsuas ntawm cov khoom lag luam.

  • Tus kws tshuaj ntsuam sau tseg omburtamab yog tus tsav tsheb me me, nrog ib ncig ntawm $ 20 lab hauv Asmeskas kev muag khoom siab tshaj plaws rau qhov qhia tau tias.

  • Pipeline tsom yuav zoo li hloov mus rau GD2-SADA, qhov twg YMAB lub hom phiaj pib noj tshuaj los ntawm YE 2022 thiab muab cov ntaub ntawv thawj zaug los ntawm ~ 5-10 cov neeg mob los ntawm 2H 2023.

  • HC Wainwright txo tus nqi lub hom phiaj rau YMAB los ntawm $ 63 txog $ 19 thiab tuav qhov Kev Ntsuas Kev Yuav.

  • Tus kws tshuaj ntsuam hais tias Y-mAbs tau pom qhov siv tau ntawm txoj hauv kev los ntawm omburtamab, tab sis tus neeg sib tw no ntsib qhov tsis paub meej yav tom ntej, thiab nws tsis tuaj yeem paub tseeb txog Y-mAbs 'kev cog lus lossis muaj peev xwm los daws cov kev txhawj xeeb uas tau tsa los ntawm FDA pawg neeg tawm tswv yim.

  • HC Wainwright cia siab tias FDA yuav tshaj tawm Tsab Ntawv Teb Ua tiav nyob rau lub asthiv tom ntej.

  • Nqe Nqis: YMAB shares tau nqis 56.56% ntawm $ 3.90 ntawm daim tshev kawg hnub Monday.

Tseeb Ratings for YMAB

Hnub

Tshaj tawm

Action

Los ntawm

Yuav

Feb 2022

HC Wainwright & Co.

Txij nkawm

yuav

Jan 2022

JP Morgan

Txij nkawm

nruab nrab

Nov 2021

JP Morgan

Downgrades

Rog

nruab nrab

Saib Ntau Tus Kws Tshuaj Ntsuam Xyuas rau YMAB

Saib Qhov Ntsuam Kev Ntsuam Xyuas Cov Ntaus Tawm Tshiab

Saib ntxiv ntawm Benzinga

Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.

© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.

Tau qhov twg los: https://finance.yahoo.com/news/analysts-slash-y-mabs-therapeutics-190154097.html